Menu
GeneBe

2-202464950-C-G

Variant summary

Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2_SupportingPS4_Supporting

This summary comes from the ClinGen Evidence Repository: The c.218C>G, (p.Ser73Ter) (NM_001204.7) variant in BMPR2 is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 2 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1; PMID:16429395). This variant has been reported in 2 pulmonary arterial hypertension probands (PS4_Supporting) (PMID:26387786 ; PMID:32581362). This variant is absent from gnomAD v2.1.1 controls (PM2_Supporting). In summary, this variant meets the criteria to be classified as pathogenic for pulmonary arterial hypertension based on the ACMG/AMP criteria applied, as specified by the ClinGen Pulmonary Hypertension VCEP (specification version 11, 1/18/2024): PVS1, PS4_Supporting, PM2_Supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA278072/MONDO:0015924/125

Frequency

Genomes: not found (cov: 32)

Consequence

BMPR2
NM_001204.7 stop_gained

Scores

4
2
1

Clinical Significance

Pathogenic reviewed by expert panel P:3

Conservation

PhyloP100: 3.01
Variant links:
Genes affected
BMPR2 (HGNC:1078): (bone morphogenetic protein receptor type 2) This gene encodes a member of the bone morphogenetic protein (BMP) receptor family of transmembrane serine/threonine kinases. The ligands of this receptor are members of the TGF-beta superfamily. BMPs are involved in endochondral bone formation and embryogenesis. These proteins transduce their signals through the formation of heteromeric complexes of two different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Mutations in this gene have been associated with primary pulmonary hypertension, both familial and fenfluramine-associated, and with pulmonary venoocclusive disease. [provided by RefSeq, May 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 10 ACMG points.

PVS1
PS4
PM2

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
BMPR2NM_001204.7 linkuse as main transcriptc.218C>G p.Ser73Ter stop_gained 2/13 ENST00000374580.10
BMPR2XM_011511687.2 linkuse as main transcriptc.218C>G p.Ser73Ter stop_gained 2/13

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
BMPR2ENST00000374580.10 linkuse as main transcriptc.218C>G p.Ser73Ter stop_gained 2/131 NM_001204.7 P1Q13873-1
BMPR2ENST00000374574.2 linkuse as main transcriptc.218C>G p.Ser73Ter stop_gained 2/122 Q13873-2
BMPR2ENST00000479069.1 linkuse as main transcriptn.125C>G non_coding_transcript_exon_variant 1/33

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Pulmonary arterial hypertension Pathogenic:2
Pathogenic, reviewed by expert panelcurationClingen Pulmonary Hypertension Variant Curation Expert Panel, ClinGenMay 03, 2024The c.218C>G, (p.Ser73Ter) (NM_001204.7) variant in BMPR2 is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 2 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1; PMID: 16429395). This variant has been reported in 2 pulmonary arterial hypertension probands (PS4_Supporting) (PMID: 26387786 ; PMID: 32581362). This variant is absent from gnomAD v2.1.1 controls (PM2_Supporting). In summary, this variant meets the criteria to be classified as pathogenic for pulmonary arterial hypertension based on the ACMG/AMP criteria applied, as specified by the ClinGen Pulmonary Hypertension VCEP (specification version 11, 1/18/2024): PVS1, PS4_Supporting, PM2_Supporting. -
Pathogenic, no assertion criteria providedresearchNIHR Bioresource Rare Diseases, University of Cambridge-- -
Pulmonary hypertension, primary, 1 Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMSep 01, 2000- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.63
D
BayesDel_noAF
Pathogenic
0.62
CADD
Pathogenic
37
DANN
Uncertain
0.99
Eigen
Pathogenic
1.0
Eigen_PC
Pathogenic
0.86
FATHMM_MKL
Uncertain
0.95
D
MutationTaster
Benign
1.0
A;A
Vest4
0.94
GERP RS
5.5

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs137852742; hg19: chr2-203329673; API